Grey Wolf Health (TSXV:WOLF) EPS (Diluted): C$0.05 (TTM As of Mar. 2026)


TSXV:WOLF Grey Wolf Health Corp TSXV:WOLF
52 GF Score
Price C$1.75
GF Value C$1.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Health EPS (Diluted)?

Grey Wolf Health TSXV:WOLF -1.69% 52 EPS (Diluted) is C$0.05 as of Mar. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 52/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Grey Wolf Health's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was C$0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.05.

Grey Wolf Health's EPS (Basic) for the three months ended in Mar. 2026 was C$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.05.

Grey Wolf Health's EPS without NRI for the three months ended in Mar. 2026 was C$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.05.

During the past 12 months, Grey Wolf Health's average EPS without NRIGrowth Rate was 157.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Grey Wolf Health  (TSXV:WOLF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Grey Wolf Health EPS (Diluted) Related Terms

Grey Wolf Health EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Grey Wolf Health's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health EPS (Diluted) Chart

Grey Wolf Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
-0.03 0.15 0.02 0.02 0.05

Grey Wolf Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.02 0.02 0.01 0.00

TSXV:WOLF vs ROL, SCI, FTDR: EPS (Diluted) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grey Wolf Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grey Wolf Health PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grey Wolf Health's PE Ratio distribution charts can be found below:

* The bar in red indicates where Grey Wolf Health's PE Ratio falls into.


TSXV:WOLF
52GF Score
Grey Wolf Health Corp TSXV:WOLF
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Wolf Health EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Grey Wolf Health's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.657-0)/35.647
=0.05

Grey Wolf Health's Diluted EPS for the quarter that ended in Mar. 2026 is calculated as

Diluted EPS (Q: Mar. 2026 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.145-0)/35.497
=0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of C$0.05 mean?
Grey Wolf Health (TSXV:WOLF) has a EPS (Diluted) of C$0.05 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Grey Wolf Health and its competitors.
Is Grey Wolf Health's EPS (Diluted) too high?
Grey Wolf Health's current EPS (Diluted) is C$0.05. Overall, Grey Wolf Health has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's EPS (Diluted) compare to ROL and SCI?
Grey Wolf Health's EPS (Diluted) of C$0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Drug Manufacturers company?
A good EPS (Diluted) depends on the Drug Manufacturers industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Grey Wolf Health and its competitors. Grey Wolf Health's current EPS (Diluted) is C$0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.75 — trading 59.1% above its estimated fair value. The current EPS (Diluted) is C$0.05. Grey Wolf Health's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current EPS (Diluted) is C$0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued. The current stock price of C$1.75 is trading 59.1% above its estimated GF Value™ of C$1.10. GuruFocus considers Grey Wolf Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • EPS (Diluted): C$0.05
  • GF Value™: C$1.10 vs. price of C$1.75 (59.1% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grey Wolf Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
52GF Score

Get the complete analysis for TSXV:WOLF

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.75
Price
C$1.10
GF Value